JNJ

#17
Johnson & Johnson
241.59 USD
+1.55%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
240.68
241.81
Rango anual
146.12
251.71
Cambio diario
+1.55%
Variación mensual
-0.99%
Variación en los últimos 6 meses
+26.72%
Cambio anual
+55.16%
Cierres anteriores
237.91
Abrir
240.84
Bid
Ask
Mínimo
240.68
High
241.81
Volumen
1 082
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 582.21 B
  • Employee 141 K
  • Founded N/A
  • CEO Joaquin Duato
  • Website www.jnj.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BMHYD1
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
18.82
Relación precio/flujo de caja
5.35
Dividendos por acción
5.14
Rendimiento por dividendo, %
2.48

Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.

Noticias